Funding will support new manufacturing facility, commercial expansion, and development of new innovative products. Oxford, UK. Oxford Nanopore Technologies Ltd, the company behind the only portable real-time DNA/RNA sequencer, MinION, has raised £100M ($140M) in new investment. Funds were raised from global investors including GIC (Singapore), CCB International (CCBI, China), Hostplus (Australia), and existing investors. The […]
Lawrence, MA — Nexcelom Bioscience, a leading provider of cell counting and analysis products for biomedical research and the biopharma industry, announced today that it has received a strategic investment from Ampersand Capital Partners. The funding will be primarily used to support Nexcelom’s worldwide growth initiatives. Founded in 2003, Nexcelom is a fast-growing supplier of innovative […]
Heidelberg, Germany and Cambridge, UK – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard), today announced the launch of a private placement of up to 4.74 million new shares to institutional investors in Europe. The price per share is set to EUR 1.40, based on a weighted average XETRA closing price of the Sygnis AG […]
Investment will grow company’s expert team, accelerate development and commercialization of gene-editing tools — including enzymes, reagents, instrumentation, and software Boulder, Colo. – Inscripta, a leading gene-editing technology company, today announced that it has closed a $55.5 million Series C funding round led by Mérieux Développement and Paladin Capital Group. Additional participants include all existing Inscripta […]
• Investment supports growing demand for biopharmaceutical manufacturing in China • Accelerates Mobius® single-use manufacturing to bolster novel drug development Wuxi, China – Merck, a leading science and technology company, today announced an additional investment to accelerate Mobius® single-use manufacturing in Wuxi, China. This investment follows a year after Merck announced its €80m Life Science investment in Nantong, […]
DARMSTADT, GERMANY Investment supports growing demand for biopharmaceutical research Builds capabilities with two new manufacturing and distribution centers in South Korea and India Accelerates Mobius® single-use manufacturing in China for biosimilars development Darmstadt, Germany – Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced an additional investment of $47 million to build a robust […]
Strand Life Sciences announced an investment by Quadria Capital, Asia’s leading healthcare focused private equity investor. India-based HealthQuad Fund and Singapore-based Heritas Venture Fund also contributed to this fund. Strand Life Sciences, formed from the business combination of Strand and Triesta, the diagnostics unit of HCG, is India’s leading specialized diagnostics company. Its expertise spans […]
Funding will help develop new treatments for the commonest cause of chronic liver disease Eagle Genomics and the Stratified Medicine Scotland Innovation Centre (SMS-IC) have been awarded a £1.7M collaborative grant from Innovate UK (the UK’s innovation agency), for a ground-breaking project that could help develop new tests and treatments for patients with non-alcoholic fatty […]
WALTHAM, Mass. — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, will make additional investments totaling $50 million as a result of the benefit of recently enacted Federal tax reform legislation in the U.S. This investment includes: $34 million for a one-time bonus of $500 to be paid to each of the company’s approximately 68,000 eligible non-executive employees […]
CAMBRIDGE, UK – EVONETIX LTD (‘Evonetix’), the Cambridge-based company pioneering an innovative approach to enable scalable and high-fidelity gene synthesis, announced today that it has completed a $12.3 million (£9 million) financing to advance the development of its technology. The financing was co-led by DCVC (Data Collective) of Palo Alto, CA and European-based Draper Esprit, and included […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
